Preimplantation Genetic Diagnosis (PGD) Market by End-users and Geography - Global Forecast and Analysis 2022-2028
SKU ID :TNV-14467874 | Published Date: 06-Sep-2019 | No. of pages: 140Description
TOC
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Fertility clinics and maternity centers - Market size and forecast 2018-2023
• Hospitals and diagnostic laboratories - Market size and forecast 2018-2023
• Research institutes - Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Advances in genetic sequencing technologies
• Rising adoption of online testing kits and services
• Growing demand for non-invasive biopsy procedures in PGD
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Genea Ltd.
• Igenomix Sl
• Illumina Inc.
• Invitae Corp.
• Laboratory Corp. of America Holdings
• Natera Inc.
• Oxford Gene Technology Group
• PerkinElmer Inc.
• Quest Diagnostics Inc.
• Thermo Fisher Scientific Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: End-user - Market share 2018-2023 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Fertility clinics and maternity centers - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Fertility clinics and maternity centers - Year-over-year growth 2019-2023 (%)
Exhibit 22: Hospitals and diagnostic laboratories - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Hospitals and diagnostic laboratories - Year-over-year growth 2019-2023 (%)
Exhibit 24: Research institutes - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Research institutes - Year-over-year growth 2019-2023 (%)
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Genea Ltd. - Vendor overview
Exhibit 46: Genea Ltd. - Business segments
Exhibit 47: Genea Ltd. - Organizational developments
Exhibit 48: Genea Ltd. - Key offerings
Exhibit 49: Igenomix Sl - Vendor overview
Exhibit 50: Igenomix Sl - Business segments
Exhibit 51: Igenomix Sl - Organizational developments
Exhibit 52: Igenomix Sl - Key offerings
Exhibit 53: Illumina Inc. - Vendor overview
Exhibit 54: Illumina Inc. - Business segments
Exhibit 55: Illumina Inc. - Organizational developments
Exhibit 56: Illumina Inc. - Geographic focus
Exhibit 57: Illumina Inc. - Segment focus
Exhibit 58: Illumina Inc. - Key offerings
Exhibit 59: Invitae Corp. - Vendor overview
Exhibit 60: Invitae Corp. - Business segments
Exhibit 61: Invitae Corp. - Organizational developments
Exhibit 62: Invitae Corp. - Geographic focus
Exhibit 63: Invitae Corp. - Key offerings
Exhibit 64: Laboratory Corp. of America Holdings - Vendor overview
Exhibit 65: Laboratory Corp. of America Holdings - Business segments
Exhibit 66: Laboratory Corp. of America Holdings - Organizational developments
Exhibit 67: Laboratory Corp. of America Holdings - Geographic focus
Exhibit 68: Laboratory Corp. of America Holdings - Segment focus
Exhibit 69: Laboratory Corp. of America Holdings - Key offerings
Exhibit 70: Natera Inc. - Vendor overview
Exhibit 71: Natera Inc. - Business segments
Exhibit 72: Natera Inc. - Organizational developments
Exhibit 73: Natera Inc. - Geographic focus
Exhibit 74: Natera Inc. - Key offerings
Exhibit 75: Oxford Gene Technology Group - Vendor overview
Exhibit 76: Oxford Gene Technology Group - Business segments
Exhibit 77: Oxford Gene Technology Group - Organizational developments
Exhibit 78: Oxford Gene Technology Group - Key offerings
Exhibit 79: PerkinElmer Inc. - Vendor overview
Exhibit 80: PerkinElmer Inc. - Business segments
Exhibit 81: PerkinElmer Inc. - Organizational developments
Exhibit 82: PerkinElmer Inc. - Geographic focus
Exhibit 83: PerkinElmer Inc. - Segment focus
Exhibit 84: PerkinElmer Inc. - Key offerings
Exhibit 85: Quest Diagnostics Inc. - Vendor overview
Exhibit 86: Quest Diagnostics Inc. - Business segments
Exhibit 87: Quest Diagnostics Inc. - Organizational developments
Exhibit 88: Quest Diagnostics Inc. - Segment focus
Exhibit 89: Quest Diagnostics Inc. - Key offerings
Exhibit 90: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 91: Thermo Fisher Scientific Inc. - Business segments
Exhibit 92: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 93: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 94: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 95: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 96: Validation techniques employed for market sizing
Exhibit 97: Definition of market positioning of vendors
Tables & Figures
Companies
Genea Ltd., Igenomix Sl, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, Natera Inc., Oxford Gene Technology Group, PerkinElmer Inc., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.
- PRICE
-
$2500$4000